Results 41 to 50 of about 54,501 (289)

Additional file 2: Table S6. of Microcirculatory assessment of patients under VA-ECMO

open access: yes, 2016
The median values of administered drugs, blood transfusions, and laboratory parameters at VA-ECMO insertion within 24 h (T1), 2–3 days after initiation of VA-ECMO (T2), and 5–6 days after initiation of VA-ECMO (T3).
Kadir Caliskan (3441230)   +10 more
core   +1 more source

Selective Inhibition of Integrin β3 Topology Provides a Safer Antithrombotic Strategy

open access: yesAdvanced Science, EarlyView.
Current integrin αIIbβ3 inhibitors effectively reduce thrombosis but also increase bleeding risk. During thrombosis, high shear blood flow can directly activate the integrin αIIbβ3 via a distinct topological change in the β3 transmembrane domain, independent of hemostatic platelet signaling.
Joonha Lee   +11 more
wiley   +1 more source

Canulación yugulo-subclavia de ECMO-VA en shock cardiogénico por tromboembolia pulmonar y síndrome de hipercoagulabilidad

open access: yesRevista Colombiana de Cardiología
El uso de soporte vital extracorpóreo es una opción en pacientes con shock cardiogénico secundario a insuficiencia ventricular derecha y tromboembolia pulmonar.
Leonardo A. Salazar-Rojas   +3 more
doaj   +1 more source

Incidence and predictors of brain infarction in neonatal patients on extracorporeal membrane oxygenation: an observational cohort study

open access: yesScientific Reports, 2022
To determine the incidence and identify predictors of brain infarctions (BI) in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). We performed a retrospective cohort study at ECMO Centre Karolinska, Stockholm, Sweden.
Sarah Kopfer   +6 more
doaj   +1 more source

Can Cardiopulmonary Rehabilitation Facilitate Weaning of Extracorporeal Membrane Oxygenation (CaRe-ECMO)? Study Protocol for a Prospective Multidisciplinary Randomized Controlled Trial

open access: yesFrontiers in Cardiovascular Medicine, 2022
Background: Mortality of patients suffering from critical illness has been dramatically improved with advanced technological development of extracorporeal membrane oxygenation (ECMO) therapy.
Yu Zheng   +19 more
doaj   +1 more source

“Intrapericardial Approach” for Venous Outflow Reconstruction in Living‐Donor Liver Transplantation for Budd‐Chiari Syndrome: Surgical Techniques and LongTerm Outcomes

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Unlike deceased‐donor liver transplantation, living‐donor liver transplantation (LDLT) for Budd‐Chiari Syndrome (BCS) presents distinctive challenges in hepatic venous (HV)‐outflow reconstruction because diseased HV–inferior vena cava (IVC) cannot be entirely replaced with healthy donor vessels.
Koichiro Hata   +4 more
wiley   +1 more source

Porcine kidney xenotransplantation: From primate models to clinical reality

open access: yesAnimal Models and Experimental Medicine, EarlyView.
In the face of a critical shortage of human donor kidneys for end‐stage renal disease patients, porcine kidney xenotransplantation has emerged as a viable solution. This field has navigated major hurdles, including immune rejection, physiological incompatibilities, potential biomechanical differences and the risk of cross‐species infection. To overcome
Zihang Guo   +3 more
wiley   +1 more source

The Predictive Power of Barotrauma from the Macklin Effect in the ARDS Population: A Comparison of COVID-19 and Non-COVID-19 ARDS—Could the Macklin Effect Serve as a Helpful Tool for Evaluating Transfer to ARDS Reference Centers?

open access: yesDiagnostics
Background: The Macklin effect recently demonstrated a high positive predictive value for barotrauma in the COVID-19 ARDS population. However, there was less evidence available regarding the ARDS population without SARS-CoV-2 infection. We aim to analyze
Alberto Marabotti   +12 more
doaj   +1 more source

Extubation of patients with COVID-19 acute respiratory failure during extracorporeal membrane oxygenation support is associated with improved survival [PDF]

open access: yesExploration of Cardiology
Aim: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or COVID-19, infection resulting in acute respiratory distress syndrome (ARDS) requiring veno-venous or veno-arterial extracorporeal membrane oxygenation (VV or VA-ECMO) support is a life-
Sean Kelleher   +8 more
doaj   +1 more source

Coronary Artery Bypass Grafting Under ECPELLA Support After Out-of-Hospital Cardiac Arrest: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT The survival and social reintegration rate of out‐of‐hospital cardiac arrest (OHCA) remains extremely low. Venoarterial extracorporeal membrane oxygenation (VA ECMO) is used to support patients with cardiogenic shock. Combining Impella (Abiomed Inc., Danvers, MA, USA) with VA ECMO (ECPELLA) is a promising strategy to stabilize circulation and ...
Moriuchi H   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy